Nebenwirkungen · Kentera (previously Oxybutynin Nicobrand)
Kentera 3.9 mg / 24 hours transdermal patch · Abschnitt 4.8 · PDF-Seite 4–5
HOS-112672 · Präparat HOS-093719
4 Rare Panic reaction#, delirium#, hallucinations#, disorientation# Nervous system Common Headache, somnolence disorders Rare Memory impairment#, amnesia#, lethargy#, disturbance in attention# Eye disorders Common Blurred vision Ear and labyrinth Common Dizziness disorders Cardiac disorders Uncommon Palpitations Vascular disorders Uncommon Urticaria, hot flushes Respiratory, thoracic Uncommon Rhinitis and mediastinal disorders Gastrointestinal Common Dry mouth, constipation, diarrhoea, nausea, disorders abdominal pain Uncommon Abdominal discomfort, dyspepsia Musculoskeletal and Uncommon Back pain connective tissue disorders Renal and urinary Uncommon Urinary retention, dysuria disorders General disorders and Very common Application site pruritis administration site Common Application site erythema, application site conditions reaction, application site rash
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-04-08T02:00:00Z · SHA-256 f16314d201d86c4de73d4a8a846ed94a7bcbbf05b4bc16677f6a496640258172 · Passage 1dd7da921674da4ad3a7539784a36814d2b4ea9df57430ca14b8abc34c6f2d79 · Zeichen 1384–2911 im Abschnitt